CLINICAL_TRIALS ClinicalTrials.gov record update

Development and Validation of New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma in CYP3A5 Expressors and Non-Expressors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04657562
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:41.745672+00:00
Published At: 2022-04-22T00:00:00+00:00
Record Updated At: 2022-04-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Immunosuppression", "Kidney Transplant Rejection", "Kidney Transplant; Complications", "Liver Transplant Rejection", "Liver Transplant; Complications", "Metabolism Medication Toxicity", "Genetic Predisposition"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-22"
protocolSection.identificationModule.nctId: "NCT04657562"
protocolSection.identificationModule.officialTitle: "Development and Validation of New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma in CYP3A5 Expressors and Non-Expressors"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.